ArticleBMC pharmacology & toxicology2017

Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes.

Shin Kawasoe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.